How This Healthtech Company is Transforming The US$11.9 Trillion Industry With A Connected, Whole-Person Approach To Care

CloudMD Software & Services Inc.’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is using its patented comprehensive healthcare platform to penetrate market share across North America

Every year, companies across North America bleed hundreds of billions in hidden costs.

The culprit? Productivity losses caused by illness and chronic diseases, including conditions such as depression, stress, and anxiety.

US employers lose an estimated $530 billion every year in lost productivity.¹

Canadian employers lose C$122 billion annually (not including C$68 billion in direct healthcare costs).²

And that was before the pandemic.

Today, the situation is more dire than ever.

Mental health cases are continuing to skyrocket.

Over the last 12 months,1 in 5 Americans sought mental health support.³

But that’s not even the worst of it…

Today, 1 in 6 US youth between the ages of 6 to 17 have a mental health condition.

Despite these troubling numbers, access to the right services has been difficult or even impossible for some.

In fact, 11.1% of Americans with a mental illness are uninsured, while 8.1% of youth had private insurance that didn’t cover mental health.⁴

Luckily, there is a saving grace that emerged to combat this worsening crisis and it has completely revolutionized the $11.9 trillion global healthcare market.⁵

We’re talking about Telehealth.

Breaking News

This sector has helped revolutionize traditional healthcare industries, by leveraging technology to provide more accessible care to patients.

A lot has changed in the world of healthcare, but nothing as big as the recent shift towards digital health.

Investors have already begun pouring billions into this growing industry and in turn, experienced some serious gains last year.

By Q3 2021, digital healthcare funding hit a record $21.3 Billion, shattering 2020’s full-year record.⁶

It’s clear that the digital health revolution is far from over, meaning there are still plenty of wins to be made.

And we’ve found a company that is not just Telehealth but rather offers a holistic healthcare solution that covers both prevention and cure using a proprietary integrated platform.

Introducing CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH), a vertically integrated health tech company that is rapidly becoming a leader in the space.

What makes this company so exciting?

CloudMD has grown significantly in the last year, and has a unique product offering – a proprietary, comprehensive healthcare platform that connects all points of a patient’s care, from ONE connected platform which is resulting in better access to care and improved outcomes. They are one of the ONLY companies to offer this holistic offering and large customers are starting to take notice.

The company has made several strategic acquisitions – including four new deals in Q2 2021 that added $96 million of annual revenue. CloudMD has a revenue run rate of $140 million and expects to turn profitable in Q3 2021.

CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) network includes: 7,000+ psychiatrists, 4,500 therapists and counsellors and 4,000 psychologists, 22,000+ family physicians, 34,000+ medical specialists, and 1,500+ allied health professionals across North America…

…And it’s just getting started.

Oh, and did we mention that CloudMD’s mission for market dominance is being supported by talented former execs from healthcare and insurance heavyweights like Teladoc, Morneau Shapell and LifeWorks?

CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is positioned to become one of the leading digital healthcare players of 2022 and beyond.

In fact, here are 6 reasons CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is a rare healthtech opportunity worth paying attention to.

REASON #1: CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is Expanding its Reach and Growing Rapidly

Thanks to a spate of strategic acquisitions plus organic growth, CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) has reported exponential revenue growth.

In the first half of 2021, its revenue climbed from C$5.9 million to C$24.4 million, while its gross profits more than quadrupled from C$2.2 million to C$9.2 million.⁷

That’s a 318% growth in revenue and a 325% increase in gross profits.

For 2021, CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is currently expecting a C$140 million revenue run rate⁸ – putting it on track for almost 200% growth and 2022 looks even stronger.

CloudMD made a number of strategic acquisitions over the last year to support its holistic platform across physical health, mental health, health navigation, specialists, assessments and education.

All of these services are connected by its proprietary technology backbone that seamlessly moves a patient through their healthcare journey and back to health faster!

REASON #2: CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) Proprietary Patented Technology is Disrupting the Healthcare Industry

CloudMD’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) business is broken into three main divisions, and its proprietary technology supports patients, providers and corporations. This technology provides the FULL healthcare ecosystem.

CloudMD’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) just received US Patent Approval for its Real Time Intervention Platform (RTIP), which is the backbone for its healthcare platform. The RTIP has already been tested and is being used by various local, state and federal agencies like the US Department of Justice and US Department of Health and Human Services.⁹

The company has leveraged its proprietary medical technology that both engages patients and clients, empowers doctors and mental health providers and adds value to payors.

CloudMD for Patients: Provides easy access to see a Doctor or Therapist online as well as through a network of hybrid on the ground clinics. A team based approach that puts the patient first and empower them to take control of the healthcare.

CloudMD for Providers: a “clinic in a box” solution that streamlines processes and functions with cloud-based medical records and billing software, plus an online patient portal that includes telemedicine, secure messaging, online booking and more!

CloudMD for Payors/Employers: The Company’s fastest growing division contributing to over half its revenue. Provides a connected system of health solutions that recognize the unique physical and mental health needs of each person. Delivers customized care programs with Nurse Navigators who support and guide patients through their journey, resulting in better access to care and improved healthcare outcomes.

A Transformative Full-Service Employer Solution

CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) has created a proprietary, revolutionary employer health solution to better manage the health and wellness of their employees and family members. With PROVEN outcomes.

But Why?

Because employers are taking WAY more of the healthcare burden because of rising costs, increase in chronic disease including mental health and public system limitations. Annual premiums paid by employers are US$19 Billion, and employer healthcare costs are projected to increase by +130% by 2025.¹⁰

CloudMD’s whole-person solution includes virtual, primary, and mental health support, as well as access to specialist and educational resources, and fixes the Employer’s challenge of using multiple vendors that are siloed and don’t work together. Employers are demanding better return on investment (ROI) on their health and wellness plans and want to see improved outcomes. Because CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) owns all its proprietary technology, and has integrated an interoperability and data sharing technology backbone, it can provide important data, analytics and outcomes in REAL-TIME to its clients.

There’s already a significant amount of employer health solutions in the market, but none have connected all these health services from one, comprehensive platform.

One of CloudMD’s key differentiators is that it uses Nurse Navigators, or personalized health coaches to guide and support individuals through their care journeys and provide valuable resources and education, resulting in better access to care and improved outcomes. Patients can access the integrated platform and connect to a nurse navigator, who creates a customized care plan and pairs individuals to the right professionals and the right care.

The early results of this comprehensive platform are incredible. CloudMD has already onboarded over a quarter of a million individuals in a short amount of time, and more importantly can provide employers valuable data and outcomes to better manage their health and wellness spend.

Leveraging technology and an array of services that provides a connected care journey and improves health outcomes. As a leader in providing better care, CloudMD’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) services have seen the following success outcomes:

215 Days Faster Access To Specialists Through Health Navigation
86% Usage Rate On Its Integrated Platform
92% Customer Satisfaction Rate
98% Overall Client Retention Rate
70% Symptom Improvement For Depression

Yet, despite all of this:

REASON #3: CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is Still Trading at a Valuation That Could Imply Substantial Upside (With Strong Growth Catalysts on the Horizon)

With a revenue run rate of $140 million CloudMD is trading at 2.4x P/S Ratio – Significantly undervalued compared to peers

For tech companies growing at this rate, it has usually become prohibitively expensive for investors to still capitalize on the opportunity.

But when it comes to CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH), there is a significant opportunity for growth as it is currently trading at a far lower price-to-sales ratio compared to its peers – giving it significant upside potential.

We’ve already seen many examples of healthtech stocks seeing rapid growth that delivered significant returns to investors who got in early.

And CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) could be next because it is still trading at a price-to-sales multiple many times below that of both its smaller and larger healthtech peers.

Meaning the market has yet to “catch up” to its true potential – even as the company sprints forward and blows past one milestone after another.

This is exceedingly rare in a technology-enabled sector, where valuations can sometimes seem to run too far ahead of revenue.

Especially when CloudMD’s proprietary platform has been acknowledged to have the widest capabilities and strongest scalability potential.

But this “valuation gap” may not last much longer because CloudMD is planning to uplist to the main exchange¹² – a move that could quickly narrow the valuation gap once more investors catch on to the company’s true potential.

And at the valuations it is currently trading at, the potential for upside is phenomenal – especially considering the company’s exponential revenue growth.

Although CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) growth numbers may seem high to some, we think it could actually be conservative.

REASON #4: CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is Embarking on a Strategic, Multi-Pronged Expansion Plan Throughout North America

Grandview Research puts the global corporate wellness market size at $58.2 billion in 2021 – and expects it to grow to $93.4 billion by 2028¹³ – as companies grasp the necessity of holistically supporting their employees’ health and wellbeing.

While CloudMD Software & Services Inc.’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) strategic acquisitions have already helped drive an exponential rise in revenue, the company is just getting started.

Now that its integrated platform is in place, CloudMD is embarking on an aggressive yet strategic expansion into the US – a major growth catalyst.

With C$50 million in cash in the bank,¹⁴ CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) already has the funds needed to drive its expansion.

By following the same disciplined strategy of only targeting highly value-accretive opportunities, CloudMD is poised to take its revenue to the next level.

Each potential acquisition will be carefully scrutinized to ensure it fits into the company’s broader vision – solving problems across the entire healthcare spectrum using the power of technology.

That means it will penetrate the healthcare market from multiple angles, from physical and mental health to health aging and health at work.

In short, CloudMD (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is pursuing business diversification that will also allow it to enhance the capabilities of all its solutions.

And it’s not just solely focusing on M&As – it’s also growing its global sales team to further boost organic growth.

Offering holistic healthcare solutions to employees is looking like one of the best ways to help solve this urgent problem by combating worker stress, boosting productivity, and increasing retention.

To really make a difference and seize the opportunity being presented, companies must offer a holistic healthcare solution that covers both prevention and cure.

An ideal solution would:

Offer everything from mental and occupational health support (both virtual and in-person) to rehabilitation and quicker access to care
Support the physical and mental health of employees while saving costs for employers through reduced absences and improved engagement
And deliver all these benefits through a single integrated digitally-enabled platform.

In other words, an ideal solution would look like what CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is already offering and is expanding across North America

CloudMD’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) solution offers¹⁵:

Virtual care
Mental health support
Health navigation (aka quicker and better access to care)
Rehabilitation (virtual and in-person)
Adjudication and assessments
Absence management
Occupational health
Educational resources

All in one!

It’s why an analyst from Stephens – one of the largest privately-owned investment banks in the US¹⁶ – calls CloudMD a “one stop shop” for employer clients with a platform that “offers the broadest scope and extensive scale to take market share.”¹⁷

And now…

REASON #5: CloudMD’s Cutting-Edge and Patented Integrated Platform Can Deliver a Personalized and Seamless End-To-End Healthcare Journey – Plus the Potential to Quickly Scale

On October 27, 2021, CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) announced that it had received US patent approval for its proprietary Real Time Intervention Platform.¹⁸

This platform is the “backbone” of all CloudMD’s offerings – connecting and integrating all its capabilities, from primary care and mental health to rehab and education.

Such integration will generate substantial synergies, allowing the company to offer the full range of its services through one single package – boosting cross-selling potential and enabling scale.

In technology, scalability is the key to success.

And in today’s world, consumers want everything to be available “all in one” in a personalized and seamless package.

That’s exactly what CloudMD’s (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) platform delivers, which is why investment bank Stephens notes that¹⁹:

“CloudMD offers a broad range (if not the broadest range) of on-site and virtual healthcare services in the industry and is growing geographical reach, making it a one-stop shop for payer/provider/employer clients.

We expect CloudMD to continue to grow market share by this breadth and depth of services and see a compounding multiple effect…”

But while CloudMD has multiple near-term catalysts on the horizon, it is much more than just a short-term play.

REASON #6: CloudMD is Also Strategically Positioned to Capitalize on Multiple Megatrends Happening in the $6.2 Trillion US Healthcare Industry

US healthcare spending stood at $3.6 trillion in 2018 and is estimated to hit $6.2 trillion by 2028.²⁰

It’s an absolutely gargantuan industry.

Which is why it’s so important for investors to pay attention to the “megatrends” – the long-term trends shaping the very structure of an industry – to get ahead of them.

BlackRock, the world’s largest asset manager, says that investing in megatrends allows for a “longer-term and less cyclical approach”.²¹

And the good news?

CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is strategically positioned at the intersection of several megatrends happening in healthcare right now, including:

A rapid “digitalization wave” spreading through healthcare, resulting in things like telehealth going mainstream
Rising expectations of healthcare consumers who now want healthcare to be as personalized, seamless, and convenient as possible
The normalization of seeking mental health treatment and an awareness that the mental health crisis is larger than most expected.
Continually rising healthcare costs handing the advantage to scalable digital platforms that can help mitigate cost increases

In short, CloudMD (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is a rapidly-growing yet undervalued company with multiple short-term growth catalysts that has also positioned itself to benefit from multiple healthcare megatrends.

CloudMD is Led by a Management Team With Over 100 Years of Healthcare Experience Who Understand How to Solve the Specific Challenges Every Player in the Healthcare System is Facing

Dr. Essam HamzaMD – CEO

Dr. Hamza completed his MD and Family Practice degree at the University of Alberta in 1999. He founded HealthVue in 2005 and grew the business to include four interconnected high-tech clinics serving over 100,000 patients. He also has extensive capital markets experience, taking private companies public and sitting on public company boards. He has successfully raised approximately $140 million and led CloudMD to a $500 million market cap with a revenue run rate of $140 million.

Karen AdamsPresident

Karen brings over 20 years of success driving growth in public, private and not-for- profit companies with a focus on supporting employee/consumer health and wellness. Karen has worked in senior executive positions at Shepell.fgi (now Morneau Shepell), SCM Insurance, Snapclarity and past Chair of Ontario Shores Centre for mental health foundation.

At Morneau Shepell, she was part of a team that helped grow the company from $25 million to $150 million in 8 years through both organic and strategic acquisition. Part of her specialty includes creating industry-leading sales teams who have been able to achieve outstanding growth – something she is bringing to her role at CloudMD.

Angel ParaviciniSVP of Business Development and Customer Success

Angel is a dedicated, passionate and growth minded executive with over 15 years’ experience in healthcare sales, sales management, vendor relations, pipeline management, relationship building, contract negotiating and training. She has a proven track record of building new distribution channels and expanding relationships through outstanding networking and product presentations.

In Angel’s most recent role, she spent over 4 years as the Head of North American Partnerships and Sales for Lifeworks, a global leader in digital healthcare. She was responsible for leading the company’s successful expansion into new mental health employer markets across North America. Before LifeWorks, she held senior leadership roles at Teladoc and HealthiestYou, leading high-performance sales and partnership development teams in North America and globally.

RECAP: 6 Reasons

CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) (FRA:6PH) is a Fast-Growing, Undervalued Opportunity in the Healthcare Space

Has already displayed exponential revenue growth stemming from both organic growth and strategic acquisitions

Proprietary technology that is disrupting the US$11.9 trillion global healthcare industry

Rolling out a strategic, multi-pronged North American expansion plan – with C$50 million of cash in the bank to fund it

Still substantially undervalued compared to its peers – P/S ratio of 2.4X is one of the lowest in the industry

Patented integrated healthcare platform gives it a great shot at capturing market share and quickly scaling

Strategically positioned to capitalize on multiple megatrends happening in the healthcare industry – from digitalization to normalization of mental health treatment

Disclaimer

footnotes:
[1] https://www.globenewswire.com/news-release/2018/11/15/1652374/0/en/Poor-Health-Costs-US-Employers-530-Billion-and-1-4-Billion-Work-Days-of-Absence-and-Impaired-Performance-According-to-Integrated-Benefits-Institute.html [2] https://www.ourcommons.ca/Content/Committee/421/FINA/Brief/BR9073636/br-external/ChronicDiseasePreventionAllianceOfCanada-e.pdf [3] https://www.nami.org/mhstats [4] https://mhanational.org/issues/state-mental-health-america [5] https://www.businesswire.com/news/home/20190625005862/en/The-11.9-Trillion-Global-Healthcare-Market-Key-Opportunities-Strategies-2014-2022---ResearchAndMarkets.com [6] https://www.beckershospitalreview.com/digital-transformation/digital-health-funding-reaches-21-3b-in-2021-5-things-to-know.html [7] https://investors.cloudmd.ca/wp-content/uploads/2021/08/Q2-2021-CloudMD-FS.pdf [8] Investor presentation [9] https://investors.cloudmd.ca/cloudmd-receives-u-s-patent-approval-for-its-proprietary-real-time-intervention-platform-rtip/ [10] https://www.mercer.ca/en/our-thinking/rising-employee-healthcare-costs.html [11] Annualized revenue run rate from investor presentation [12] Investor presentation [13] https://www.grandviewresearch.com/industry-analysis/corporate-wellness-market [14] https://investors.cloudmd.ca/wp-content/uploads/2021/08/Q2-2021-CloudMD-FS.pdf [15] https://investors.cloudmd.ca/for-enterprise/ [16] https://en.wikipedia.org/wiki/Stephens_Inc. [17] Stephens Analyst report dated July 1, 2021 [18] https://finance.yahoo.com/news/cloudmd-receives-u-patent-approval-113000361.html [19] Stephens Analyst report dated July 1, 2021 [20] https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/us-healthcare-spending-to-hit-6-2-trillion-by-2028-growth-set-to-outpace-gdp-57739003 [21] https://www.blackrock.com/ch/individual/en/themes/megatrends

Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of and sponsored by, CloudMD Software & Services Inc. and Market Jar Media Inc. has or expects to receive from CloudMD Software & Services Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) one hundred fourteen thousand CAD for 31 days (22 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on WealthyMillionaire.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on WealthyMillionaire.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.

6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding CloudMD Software & Services Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to CloudMD Software & Services Inc.’s industry; (b) market opportunity; (c) CloudMD Software & Services Inc.’s business plans and strategies; (d) services that CloudMD Software & Services Inc. intends to offer; (e) CloudMD Software & Services Inc.’s milestone projections and targets; (f) CloudMD Software & Services Inc.’s expectations regarding receipt of approval for regulatory applications; (g) CloudMD Software & Services Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) CloudMD Software & Services Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute CloudMD Software & Services Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) CloudMD Software & Services Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) CloudMD Software & Services Inc.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) CloudMD Software & Services Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of CloudMD Software & Services Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) CloudMD Software & Services Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact CloudMD Software & Services Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing CloudMD Software & Services Inc.’s business operations (e) CloudMD Software & Services Inc. may be unable to implement its growth strategy; and (f) increased competition.

Except as required by law, CloudMD Software & Services Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does CloudMD Software & Services Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither CloudMD Software & Services Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document.

7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of CloudMD Software & Services Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of CloudMD Software & Services Inc. or such entities and are not necessarily indicative of future performance of CloudMD Software & Services Inc. or such entities.